Update on the use of direct oral anticoagulants for the prevention and treatment of thromboembolism

被引：0
|
作者：
Jacobs, Anna [1 ,2 ]
Kabra, Rajesh [3 ]
Das, Pranab [4 ]
Oliphant, Carrie S. [1 ,2 ]
机构：
[1] Methodist Univ Hosp, Dept Pharm, 1265 Union Ave, Memphis, TN 38104 USA
[2] Univ Tennessee, Coll Pharm, Dept Clin Pharm, 920 Madison Ave, Memphis, TN 38163 USA
[3] Univ Tennessee, Hlth Sci Ctr, Div Cardiol, 1325 Eastmoreland Ave Suite 460, Memphis, TN 38104 USA
[4] St Francis Cardiol Associates, 6005 Pk Ave,Suite500 B, Memphis, TN 38119 USA
来源：
FUTURE CARDIOLOGY | 2018年 / 14卷 / 01期
关键词：
apixaban; atrial fibrillation; betrixaban; dabigatran; edoxaban; review; rivaroxaban; venous thromboembolism;
D O I：
10.2217/fca-2017-0045
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Following publication of our review article 4 years ago, there has been an uptake in the use of nonvitamin K oral antagonists, also known as direct oral anticoagulants. The most recent Xa inhibitors to receive approval are edoxaban, which has been approved for use in both atrial fibrillation and venous thromboembolism prevention and betrixaban, which has been approved in the USA for extended thromboprophylaxis in the medically ill population. Additional analyses of certain types of atrial fibrillation patients have now become available. Ongoing prescriber vigilance is recommended as additional information continues to emerge with this class of medications. The purpose of this paper is to provide an update on the use of the direct oral anticoagulant agents for the prevention and treatment of thromboembolism.
引用
收藏
页码：89 / 99
页数：11
相关论文
共 50 条
  • [1] Novel oral anticoagulants for the prevention and treatment of thromboembolism
    Oliphant, Carrie S.
    Jacobs, Anna
    Kabra, Rajesh
    Das, Pranab
    FUTURE CARDIOLOGY, 2013, 9 (06) : 849 - 861
  • [2] Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients
    Song, Andrew B.
    Rosovsky, Rachel P.
    Connors, Jean M.
    Al-Samkari, Hanny
    VASCULAR HEALTH AND RISK MANAGEMENT, 2019, 15 : 175 - 186
  • [3] Direct oral anticoagulants for venous thromboembolism treatment and prophylaxis
    Yorkgitis, Brian K.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2016, 29 (08): : 24 - 29
  • [4] Prevention and Treatment of Bleeding with Direct Oral Anticoagulants
    Crawley, R. Monroe
    Anderson, Rachel L.
    DRUGS, 2020, 80 (13) : 1293 - 1308
  • [5] The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism
    Mavrakanas, Thomas
    Bounameaux, Henri
    PHARMACOLOGY & THERAPEUTICS, 2011, 130 (01) : 46 - 58
  • [6] Direct oral anticoagulants: An update
    Franco Moreno, Ana Isabel
    Martin Diaz, Rosa Maria
    Navarro, Maria Jose Garcia
    MEDICINA CLINICA, 2018, 151 (05): : 198 - 206
  • [7] The use of direct oral anticoagulants in the treatment of acute venous thromboembolism in cancer patients
    Abdel-Razeq, Hikmat
    Finianos, Antoine
    Taher, Ali T.
    EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (06) : 487 - 494
  • [8] The Use of Direct Oral Anticoagulants in the Management of Venous Thromboembolism in Patients With Obesity
    Younis, Moustafa
    Elkaryoni, Ahmed
    Williams, George W., II
    Jakhar, Ishaan
    Suman, Sahil
    Simon, Stephen
    Salzman, Gary
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (08)
  • [9] Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Japan
    Nakamura, Mashio
    Yamada, Norikazu
    Ito, Masaaki
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2017, 24 (06) : 560 - 565
  • [10] Direct Oral Anticoagulants and Their Use in Treatment and Secondary Prevention of Acute Symptomatic Venous Thromboembolism
    Granziera, Serena
    Hasan, Arjumand
    Cohen, Alexander T.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2016, 22 (03) : 209 - 221
12345